A gut microbe shields mice from Parkinson’s-like brain damage

Parkinson's disease is usually thought of as a brain disease, but many patients notice gut trouble—constipation above all—years or even decades before their hands begin to tremble. That timing has led researchers to ask whether the illness sometimes begins in the intestine, and whether treating the gut early could change what later happens in the brain.

A team at National Taiwan University and National Taiwan University Hospital, working with colleagues at Chang Gung University and the National Laboratory Animal Center, has now tested that idea directly. They studied mice carrying G2019S, a mutation in a gene called LRRK2 that is one of the most common inherited risk factors for Parkinson’s disease—and that also raises the risk of inflammatory bowel disease.

The mice were raised completely germ-free, so the researchers could control exactly which bacteria entered their guts. The study is published in the Journal of Advanced Research.

Sign up for Blog Updates